Antibodies are the leading course of therapeutics, thanks largely to their capability to communicate with distinct ligand conformations to be able to elicit particular biological responses. However, discovery of recent molecules binding distinct epitopes is time intensive and demanding, especially for cases necessitating a certain antibody-ligand o